Overview


According to FutureWise analysis the market for IVD Antibodies in 2023 is US$ 4.3 billion, and is expected to reach US$ 7.7 billion by 2031 at a CAGR of 7.1.

In vitro diagnostics are commonly used for disease screening, therapeutic monitoring, and ensuring blood is safe for transfusions. Because of the rising prevalence of chronic and infectious diseases worldwide, as well as the need to diagnose chronic diseases early in order to receive proper treatment, IVD antibodies are in high demand. IVD antibodies are unique diagnostic tools in clinical diagnostics and research. As a result, they are now a required component of many diagnostic assays used to diagnose chronic diseases such as cancer, tuberculosis, and HIV. The IVD antibodies, in addition to detecting diseases at an early stage, allow medical professionals to initiate treatment. Immunonephelometric and sandwich ELISA are two immunology methods that make extensive use of IVD antibodies.

Antibodies are frequently used in IVD testing to identify and measure specific target molecules. They include cytokines that can be assessed to detect an inflammatory or autoimmune condition, bacterial or viral antigens that can be used to determine the presence of an infection, and different biomarkers of cancer, cardiovascular disease, or neurological disorders. A wide variety of sample types may accurately detect even low-abundance analytes owing to antibodies' excellent specificity and sensitivity. It's crucial to understand that IVD-grade antibodies are distinct from those that are exclusively intended for research purposes. Since IVD antibodies are frequently employed in a clinical context, they are subject to several licensing procedures to ensure the safety and effectiveness of the product. The IVD tests that use antibodies include lateral flow immunoassays for evaluating urine, saliva, or milk samples, ELISAs to analyse material such as blood or serum, and IHC analysis of tissue sections.

FutureWise Market Research has published a report that provides an insightful analysis of IVD antibodies market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the IVD antibodies market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Abcam plc.
  • Thermo Fisher Scientific
  • Rockland Immunochemicals Inc.
  • GenScript
  • Bio-Rad Laboratories, Inc.
  • SDIX, LLC.
  • Advy Chemical Pvt. Ltd.
  • MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD.
  • HyTest Ltd.
  • Abbott

(Note: The list of the major players will be updated with the latest market scenario and trends)

The global rise in the prevalence of chronic and infectious diseases such as HIV, hepatitis, and cancer, as well as cardiovascular disorders, malaria, and hepatitis, is a significant driver of the IVD antibody market's expansion. This trend is expected to continue throughout the forecast period. IVD antibodies are highly sought-after diagnostic products that can be used to detect early signs of cancer in hospitals and diagnostic laboratories. The rapid rise in the incidence of various types of cancer around the world will ultimately drive the IVD antibody market growth during the forecast period. The IVD antibody market will continue to expand as a result of increased research and development and rising investments in medical research by both government and non-governmental organisations. IVD antibodies are in high demand as diagnostic products can be used in hospitals and diagnostic laboratories. However, there are some obstacles to the growth of the IVD antibody market. These factors include higher IVD antibody prices, lower product penetration, and a lack of adequate healthcare facilities in low-income countries. The slow pace of product approval and research also has a negative impact on market growth.

By Product Type

  • Cardiac Markers
  • Tumor Markers
  • Kidney Injury Markers
  • Infection And Inflammation Antibodies

By Application

  • Immunology
  • Cancer
  • Cardiovascular Diseases

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Homecare settings
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The market for IVD antibodies in North America is highest due to rising drug research and development activities, increased product penetration, rising cancer, and cardiovascular disease rates, the availability of favourable reimbursement policies, and the presence of major IVD antibody producers. Due to the rise in cancer cases, the existence of a highly developed healthcare sector, increasing research and development expenditures, and the presence of major pharmaceutical and biopharmaceutical giants, there is an increased need for IVD antibodies throughout the United States. One of the world's largest healthcare sectors is located in the United States. The nation invests enormous sums of money each year in drug development and medical research. In a similar vein, the market for IVD antibodies will expand throughout the forecast period owing to the rising popularity of point-of-care diagnostics. Additionally, based on product type; infection & inflammation hold biggest market share in global market in 2022.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the IVD Antibodies Market By Product Type, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   IVD Antibodies Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of IVD Antibodies Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   IVD Antibodies Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   IVD Antibodies Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiac Markers
        2. Tumor Markers
        3. Kidney Injury Markers
        4. Infection and Inflammation Antibodies

  • 8.   IVD Antibodies Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunology
        2. Cancer
        3. Cardiovascular Diseases

  • 9.   IVD Antibodies Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratories
        3. Homecare settings
        4. Others

  • 10.   North America IVD Antibodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America IVD Antibodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe IVD Antibodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific IVD Antibodies Market Analysis 2017-2022 and Forecast 2023-2031(USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abcam plc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Rockland Immunochemicals Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. GenScript
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-Rad Laboratories, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. SDIX, LLC.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Advy Chemical Pvt. Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. HyTest Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Abbott
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients